Covid-19: Pfizer Vaccine Works Against Indian Variant — Co-founder

'Dotun Akintomide
Writer
Why Africa May Be Left Behind In Covid-19 Vaccination - WHO

Ad

Audu Ogbeh: Tinubu, Obasanjo, Eminent Nigerians Mourn

By Abiola Olawale Eminent Nigerians have expressed sadness over the death of Chief Audu Ogbeh, former Minister of Agriculture and Rural Development and ex-National Chairman of the People’s Democratic Party (PDP). President Bola Ahmed Tinubu, former President Olusegun Obasanjo, and other prominent Nigerians have paid heartfelt tributes to the late statesman, describing him as a…

The Controversial East African Crude Oil Pipeline Is Nearing Completion

The East African Crude Oil Pipeline (EACOP), 64.5% complete, will connect Uganda’s oilfields to Tanzania’s Port of Tanga for global crude exports. Despite $3.6 billion already spent and new financing secured, the project continues to face backlash from human rights groups and environmental activists. Critics cite displacement of communities and threats to ecosystems, while developers…

2027: Amaechi Vows to Defeat Tinubu if He Wins ADC’s Presidential Ticket

• Accuses APC of diverting public funds for elections... By Abiola Olawale  Former Minister of Transportation and two-term governor of Rivers State, Rotimi Amaechi, has asserted that he would defeat President Bola Tinubu in the 2027 Nigerian presidential election if he wins the presidential ticket of the Action Democratic Congress (ADC). Speaking during a Twitter…

Ad

BioNTech co-founder and a German Oncologist, Ugur Sahin on Wednesday, has admitted that the vaccine that his company jointly developed with Pfizer works against the Indian variant of Covid-19.

According to Sahin, investigations revealed that the Pfizer-BioNTech vaccine works against the B.1.617 COVID-19 variant in India.

The Pfizer-BioNTech vaccine was developed by BioNTech, a German Company and Pfizer, an American Company.

The BioNTech-Pfizer vaccine was the first to win authorisation and has since been deployed to several countries.

According to Sahin, after series of tests conducted in India, it was discovered that the vaccine works against some victims of the B.1.617 variant in India.

In his words, “We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” said Sahin.

“The vaccine is cleverly built and I’m convinced the bulwark will hold. And if we have to strengthen the bulwark again, then we will do it, that I’m not worried about,” he added.

India is currently facing another spike of Covid-19 cases. There are also fears that a new variant could be the reason for the surging new cases of the virus.

According to the data obtained from the Union Health Ministry of India, a total of 360,960 COVID-19 cases, recording fresh fatalities of 3,293, was recorded on Wednesday. The total tally of India’s COVID-19 cases stands at 17,997,267 with 201,187 deaths, as of Wednesday.

The World Health Organization has said the B.1.617 variant of Covid-19 first found in India has been detected in at least 17 countries.

Ad

X whatsapp